pentosidine has been researched along with cimadronate in 1 studies
| Studies (pentosidine) | Trials (pentosidine) | Recent Studies (post-2010) (pentosidine) | Studies (cimadronate) | Trials (cimadronate) | Recent Studies (post-2010) (cimadronate) |
|---|---|---|---|---|---|
| 577 | 34 | 205 | 105 | 3 | 4 |
| Protein | Taxonomy | pentosidine (IC50) | cimadronate (IC50) |
|---|---|---|---|
| Farnesyl pyrophosphate synthase | Homo sapiens (human) | 0.1863 | |
| Farnesyl pyrophosphate synthase | Leishmania donovani | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komatsubara, S; Marumo, K; Mashiba, T; Mori, S; Saito, M | 1 |
1 other study(ies) available for pentosidine and cimadronate
| Article | Year |
|---|---|
Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.
Topics: Animals; Arginine; Biomechanical Phenomena; Bone Density Conservation Agents; Bone Resorption; Calcification, Physiologic; Calcium; Collagen; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Glycation End Products, Advanced; Lysine; Male; Phosphorus; Ribs | 2008 |